logo.jpg
Vallon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 13, 2021 09:15 ET | Vallon Pharmaceuticals Inc.
- Company remains on track to report pivotal data from lead program, ADAIR, in second half 2021 - Novel abuse-deterrent platform technology enables pipeline expansion opportunities across multiple...
Cellectis Logo.png
Monthly information on share capital and company voting rights
May 10, 2021 16:30 ET | Cellectis Inc.
NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
Syneos Health_rgb_r.jpg
Syneos Health Leaders Recognized For Visionary Healthcare Expertise Through HBA
May 06, 2021 07:30 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Lynn Hamilton, Senior...
researchdrivelogo.jpg
Global Culture Media Market to Garner Revenue of $5,398.6 million at a CAGR of 7.7% from 2020-2027 - Exclusive Report [Pages-230] by Research Dive
May 05, 2021 09:15 ET | Research Dive
New York, USA, May 05, 2021 (GLOBE NEWSWIRE) -- Research Dive recently published a new report titled, “Culture Media Market, by Media type (Dehydrated Culture Media, Prepared Culture Media,...
Syneos Health_rgb_r.jpg
Syneos Health Launches “Lab to Life” Enterprise Partnership with Komodo Health
May 03, 2021 07:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced today it has expanded its relationship...
Beroni Logo @ Dec 2019.png
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit
April 27, 2021 08:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, April 27, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise...
Cellectis Logo.png
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021
April 26, 2021 16:39 ET | Cellectis Inc.
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS). Dear Shareholders, In the context of the Covid-19 pandemic and in accordance with Ordinance no....
Genovac Antibody Discovery Launches in NDSU Research and Technology Park
April 26, 2021 12:59 ET | Genovac
Fargo, North Dakota, April 26, 2021 (GLOBE NEWSWIRE) -- Genovac Antibody Discovery has launched in the United States following a management buyout of an antibody discovery business unit owned by...
sitryx-no-molecule-no-i-wb.png
Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer
April 15, 2021 02:00 ET | Sitryx Therapeutics
Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer Oxford, UK – 15 April 2021 – Sitryx (“the Company”), a biopharmaceutical company...
Cellectis Logo.png
Monthly information on share capital and company voting rights
April 12, 2021 16:30 ET | Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal...